Anebulo Pharmaceuticals, Inc.
ANEB
$1.14
$0.065.56%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 125.73% | -83.52% | -72.49% | -63.66% | -59.37% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 113.34% | -40.66% | -2.11% | -16.47% | -67.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 125.86% | -78.31% | -69.94% | -62.79% | -59.64% |
|
|
|||||
| Total Current Assets | 125.86% | -78.31% | -69.94% | -62.79% | -59.64% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -34.89% | -- | -- | -- | -- |
| Total Assets | 111.19% | -72.72% | -65.10% | -58.46% | -55.59% |
|
|
|||||
| Total Accounts Payable | 0.25% | -55.45% | -70.74% | -32.58% | -8.05% |
| Total Accrued Expenses | -19.51% | 110.56% | -80.50% | -32.04% | -32.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -13.30% | -20.57% | -75.62% | -32.24% | -26.14% |
|
|
|||||
| Total Current Liabilities | -13.30% | -20.57% | -75.62% | -32.24% | -26.14% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -13.30% | -20.57% | -75.62% | -32.24% | -26.14% |
|
|
|||||
| Common Stock & APIC | 23.43% | 2.19% | 2.08% | 2.06% | 2.17% |
| Retained Earnings | -12.29% | -13.27% | -14.34% | -17.09% | -20.21% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 130.64% | -77.21% | -64.04% | -61.48% | -58.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 130.64% | -77.21% | -64.04% | -61.48% | -58.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 130.64% | -77.21% | -64.04% | -61.48% | -58.19% |
|
|
|||||